UB Paderborn / Katalog / Suche / in CDI

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2008-06, Vol.590 (1), p.141-144

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients

Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis

Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long‐Term Follow‐Up

Was ist gesichert in der Therapie von Vorhofflimmern?

What is confirmed in the treatment of atrial fibrillation?

Recurrence of Atrial Fibrillation in Dependence of Left Atrial Volume Ιndex

Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study

Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies

Impact of baseline left ventricular ejection fraction on long‐term outcomes in cardiac contractility modulation therapy

Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study

Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudin

Sex-differences in short QT syndrome: A systematic literature review and pooled analysis

Arrhythmic events in Brugada syndrome patients induced by fever

Cardiac impact of R-wave triggered irreversible electroporation therapy

Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome

Determinants of arterial stiffness in patients with atrial fibrillation

Iatrogenic Aspects of Cardiac Electrophysiology

Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine

research paper: Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells

Activated protein C inhibits the release of proinflammatory cytokines and chemokines from the monocytic cell line THP-1

Biological relevance of anti-recombinant hirudin antibodies: Results from in vitro and in vivo studies: Hirudin

A New Therapeutic Option by Subcutaneous Recombinant Hirudin in Patients with Heparin-induced Thrombocytopenia Type II

Benchmarking von Krankenhausinformationssystemen – eine vergleichende Analyse deutschsprachiger Benchmarkingcluster

Backings and targets for chemical and nuclear studies of transactinides with TASCA

Aktive Filter

Suchergebnisse filtern